Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 96.41%-169.88K | 103.08%47.8K | -1,119.42%-5.14M | -277.29%-7.06M | 41.39%-142.05K | -92.84%-4.74M | -93.43%-1.55M | -124.77%-421.12K | 80.99%-1.87M | 93.30%-242.36K |
| Net income from continuing operations | 74.33%-1.02M | 40.26%-2.23M | -67.14%-3.01M | -0.46%-11.53M | 64.39%-2.01M | -110.72%-3.99M | -44.49%-3.73M | -32.71%-1.8M | -35.91%-11.48M | -164.89%-5.65M |
| Operating gains losses | -1,599.38%-1.44M | -78.67%89.04K | 379.15%589.28K | 264.05%688.99K | 330.15%244.48K | 587.08%95.82K | 384.39%417.35K | 183.47%122.99K | -375.33%-420K | -254.00%-106.23K |
| Depreciation and amortization | -16.77%45.62K | -42.60%46.73K | -2.85%101.87K | -43.99%317.32K | -46.28%86.65K | -51.42%54.82K | -58.22%81.42K | 7.49%104.86K | 109.92%566.58K | 107.71%161.31K |
| Asset impairment expenditure | 9,161.88%614.67K | --0 | -47.49%942 | -99.94%1.33K | -101.35%-31.14K | 79.14%-6.78K | --1.58K | --1.79K | --2.29M | --2.31M |
| Unrealized gains and losses of investment securities | ---210K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Remuneration paid in stock | -84.40%138.71K | -44.68%209.09K | 268.75%224.34K | 432.77%1.69M | 1,648.27%362.89K | 1,062.33%888.95K | 589.93%377.96K | -63.20%60.84K | -52.76%317.33K | -78.20%20.76K |
| Deferred tax | 1,275.80%56.51K | 16.06%9.84K | ---- | 182.16%25.57K | 170.34%21.89K | ---4.81K | --8.48K | ---- | -577.87%-31.12K | -1,732.79%-31.12K |
| Other non cashItems | ---- | -99.57%8.43K | -41.23%6.33K | 265.66%2.29M | -67.96%106.58K | 52.85%18.67K | 599.64%1.96M | 20.32%10.77K | 164.84%626.57K | 151.17%332.59K |
| Change In working capital | 191.40%1.64M | 386.21%1.92M | -382.02%-3.05M | -108.60%-538.52K | -60.29%1.08M | -151.67%-1.8M | -147.60%-669.27K | -63.19%1.08M | 330.43%6.26M | 253.63%2.71M |
| -Change in receivables | 45.96%2.79M | 2,880.08%1.75M | 15,310.65%867.16K | -229.29%-3.99M | -183.45%-5.91M | 123.66%1.91M | -98.57%58.8K | 84.16%-5.7K | 528.87%3.08M | -28.30%7.08M |
| -Change in inventory | 96.69%-98.83K | 106.57%35.79K | -325.46%-580.17K | 219.63%1.85M | 313.50%5.12M | -8.94%-2.98M | -312.05%-544.63K | 183.44%257.32K | -447.50%-1.55M | -4.85%1.24M |
| -Change in prepaid assets | 5.80%4.58M | 1,409.92%9.13M | -7.78%-5.46M | -227.46%-5.22M | -221.38%-5.08M | 1,456.02%4.32M | 251.29%604.48K | -15,852.96%-5.07M | 2,403.73%4.09M | 6,058.71%4.18M |
| -Change in payables and accrued expense | 176.93%1.44M | -283.91%-2.03M | -12.18%-1.73M | -75.63%847.18K | 151.06%3.34M | -119.47%-1.87M | 140.96%1.1M | -148.22%-1.54M | 257.51%3.48M | 48.07%-6.53M |
| -Change in other current assets | -118.38%-181 | 1,314.84%2.58K | 106.18%624 | -111.35%-10.56K | 85.61%-1.64K | --985 | -99.83%182 | -421.76%-10.1K | 193.28%93.04K | 88.60%-11.37K |
| -Change in other current liabilities | --0 | --0 | --0 | -516.46%-240.73K | --0 | -4,096.54%-248.47K | 104.82%2.78K | -73.46%4.95K | -217.46%-39.05K | -1,250.23%-382.39K |
| -Change in other working capital | -140.13%-7.06M | -267.75%-6.97M | -48.16%3.86M | 314.58%6.22M | 225.93%3.61M | -1,421.55%-2.94M | -2,281.41%-1.9M | 21,723.79%7.44M | -38,734.57%-2.9M | -1,154.10%-2.86M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 96.41%-169.88K | 103.08%47.8K | -1,119.42%-5.14M | -277.29%-7.06M | 41.39%-142.05K | -92.84%-4.74M | -95.35%-1.55M | -124.77%-421.12K | 80.99%-1.87M | 93.30%-242.36K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 463.57%12.95K | -383.34%-42.19K | -253.47%-14.42K | -1,208.28%-21.8K | -6.81%-2.41K | -392.13%-3.56K | 99.81%-8.73K | 99.48%-4.08K |
| Net PPE purchase and sale | --0 | --0 | --12.95K | -383.34%-42.19K | -253.47%-14.42K | -1,208.28%-21.8K | -6.81%-2.41K | --0 | 74.01%-8.73K | -213.09%-4.08K |
| Net business purchase and sale | ---- | --0 | --0 | ---- | ---- | ---- | --0 | ---3.56K | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | 463.57%12.95K | -383.34%-42.19K | -253.47%-14.42K | -1,208.28%-21.8K | -6.81%-2.41K | -392.13%-3.56K | 99.81%-8.73K | 99.48%-4.08K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -99.29%35.17K | -131.04%-1.19M | 868.21%6.42M | 742.44%6.93M | 25.27%-1.03M | 67.49%4.96M | 64.47%3.83M | 73.60%-836.27K | -89.65%822.3K | -134.34%-1.38M |
| Net issuance payments of debt | -97.49%35.17K | 17.60%-1.19M | 82.56%-145.83K | -166.01%-2.61M | -39.46%-1.73M | -52.49%1.4M | -293.99%-1.44M | 75.65%-836.27K | -115.18%-979.44K | -130.49%-1.24M |
| Net common stock issuance | --0 | --0 | --4.71M | 194.60%5.28M | -2,615.97%-3.56M | --0 | 232.67%5.28M | --0 | 20.67%1.79M | -108.82%-131.04K |
| Proceeds from stock option exercised by employees | --0 | --0 | --1.86M | 42,550.17%4.25M | --4.25M | --3.56M | --0 | --0 | 159.56%9.98K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -99.29%35.17K | -131.04%-1.19M | 868.21%6.42M | 742.44%6.93M | 25.27%-1.03M | 67.49%4.96M | 64.47%3.83M | 73.60%-836.27K | -89.65%822.3K | -134.34%-1.38M |
| Net cash flow | ||||||||||
| Beginning cash position | -40.21%1.74M | 322.76%2.66M | -31.03%1.42M | -27.86%2.06M | -7.69%3.43M | -8.35%2.91M | -55.99%629.47K | -27.86%2.06M | -69.87%2.85M | 8.30%3.71M |
| Current changes in cash | -167.65%-134.71K | -150.12%-1.14M | 203.27%1.3M | 83.83%-170.83K | 26.98%-1.19M | -60.35%199.12K | 48.56%2.28M | 14.14%-1.26M | 83.90%-1.06M | -309.10%-1.62M |
| Effect of exchange rate changes | -126.69%-85.16K | 20,684.75%220.73K | 64.00%-60.41K | -278.79%-467.9K | -2,569.48%-822.33K | 777.40%319.08K | -99.49%1.06K | -465.90%-167.77K | 584.76%261.71K | 82.76%-30.81K |
| End cash Position | -55.67%1.52M | -40.21%1.74M | 322.76%2.66M | -31.03%1.42M | -31.03%1.42M | -7.69%3.43M | -8.35%2.91M | -55.99%629.47K | -27.86%2.06M | -27.86%2.06M |
| Free cash from | 96.43%-169.88K | 103.07%47.8K | -1,119.42%-5.14M | -277.78%-7.1M | 36.51%-156.47K | -93.60%-4.76M | -95.10%-1.55M | -124.78%-421.12K | 80.97%-1.88M | 93.19%-246.43K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.